Prot #HPC-PK-005: A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and its Metabolites in Blood and Urine of Women with a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm D

Project: Research project

StatusFinished
Effective start/end date9/9/139/9/16

Funding

  • Cycle Solutions, Inc. (Prot #HPC-PK-005)
  • K-V Pharmaceutical Company (Prot #HPC-PK-005)